SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II, Human is a potent peptide hormone that plays a critical role in regulating blood pressure and fluid balance. It interacts specifically with angiotensin receptors, triggering a cascade of intracellular signaling pathways that influence vascular smooth muscle contraction and aldosterone secretion. Its rapid kinetics allow for swift physiological responses, while its unique structure facilitates high-affinity binding, enhancing its effectiveness in modulating cardiovascular functions. | ||||||
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
As mentioned, the primary activator of MYLK is the calcium ion, especially when it binds to calmodulin, forming the calcium-calmodulin complex. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
While this is traditionally known as an inhibitor of MYLK, in certain concentrations and contexts, it might produce varying effects on MYLK activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
This is a broad-spectrum kinase inhibitor, but again, in specific settings, it might modulate MYLK activity. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
This is a calmodulin antagonist, which can affect MYLK's activation state by inhibiting its primary activator, calmodulin. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
While mainly an inhibitor of myosin II, it's noteworthy for researchers studying MYLK because of its influence on the broader myosin pathway. | ||||||